Vertex (VRTX) PT Lifted to $131 at Baird Following NACFC

Baird analyst Brian Skorney reiterated an Outperform rating and boosted his price target on Vertex (NASDAQ: VRTX) to $131.00 (from $119.00) saying there are multiple reasons to be bullish following NACFC.

Skorney commented, "We were encouraged by both the physician response to Vertex’s various data sets as well as management's updated strategy at the North American Cystic Fibrosis Conference over the weekend. We felt there were multiple meaningful positives, offsetting a handful of negative data points, and leading us to raise our target price to $131."

For an analyst ratings summary and ratings history on Vertex click here. For more ratings news on Vertex click here.

Shares of Vertex closed at $104.73 yesterday.

You May Also Be Interested In

• Citi Downgrades Molson Coors (TAP) to Sell, 'Cycling 2023 Could Be a Mountain Too Hard to Climb'
• Tesla (TSLA) PT Lowered to $180 at Mizuho
• Pentair (PNR) PT Raised to $85 at TD Cowen